Name: Antioxidants and Redox Signaling
Address: United States

Antioxidants and Redox Signaling

Claimed

Redox

United States

General Description

Abbreviation

Antioxid Redox Signal

ISSN(online)

1557-7716

ISSN(print)

1523-0864

Subject

Redox

Open Access Journal

Hybrid

Licensing

CC BY

Yes

Peer Review

Impact Factor

Indices

Chemical Abstracts Service (CAS), Google Scholar, ProQuest, Pubmed, SCImago, Scopus, UGC-CARE List

Language

English

All journal details can be verified on https://clarivate.com/

Contact Information

Website

https://home.liebertpub.com/publicati...

Detailed Information

Aim & Scope

Antioxidants & Redox Signaling (ARS) is the leading peer-reviewed journal dedicated to understanding the vital impact of oxygen and oxidation-reduction (redox) processes on human health and disease. The Journal explores key issues in genetic, pharmaceutical, and nutritional redox-based therapeutics. Cutting-edge research focuses on structural biology, stem cells, regenerative medicine, epigenetics, imaging, clinical outcomes, and preventive and therapeutic nutrition, among other areas.

ARS has expanded to create two unique foci within one journal: ARS Discoveries and ARS Therapeutics. ARS Discoveries (24 issues) publishes the highest-caliber breakthroughs in basic and applied research. ARS Therapeutics (12 issues) is the first publication of its kind that will help enhance the entire field of redox biology by showcasing the potential of redox sciences to change health outcomes.